Zevra Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference being held virtually on Tuesday, February 13, 2024, at 9:20 a.m. ET. Additionally, members of Zevra’s management team will be available for one-on-one investor meetings with registered attendees during the conference from February 13-14, 2024.
Related news for (ZVRA)
- Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- 24/7 Market News Snapshot 06 October, 2025 – Zevra Therapeutics, Inc. Common Stock (NASDAQ:ZVRA)
- Zevra Therapeutics Announces Details for Q1 2025 Financial Results Call
- Zevra Therapeutics to Participate in the Citizens Life Science Conference
- Zevra Therapeutics Files Preliminary Proxy